Like other GLP-1 receptor agonists, oral semaglutide also carries a black box warning for potential risk of thyroid C-cell tumors and a contraindication for use in patients with a personal or family history of medullary thyroid cancer or in patients with multiple endocrine neoplasia syndrome type 2
doi:10.3390/diagnostics14242829 222
This one from dietitian Lauren features grape juice and peanut butter powder to give you that Peanut Butter & Jelly flavor we love so much
The FDA stated last week that "compounded drugs are not FDA approved." While the agency recognized the potential benefits in the face of shortages, it also highlighted several concerns, including dosage, salt compounded forms and illegal versions
Retatrutide and cagrilintide Are synthetic peptides and investigational new drugs in multiple clinical research trials for the treatment and management of obesity and T2D
Injectable semaglutide is generally more effective for weight loss and controlling blood sugar, especially for non-diabetic individuals aiming for significant weight reduction
